

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 7.88576931 |
| 2 | ensheathment of neurons (GO:0007272) | 7.55471521 |
| 3 | axon ensheathment (GO:0008366) | 7.55471521 |
| 4 | myelination (GO:0042552) | 7.52136674 |
| 5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 7.37645957 |
| 6 | synaptic vesicle maturation (GO:0016188) | 7.32288257 |
| 7 | glutamate secretion (GO:0014047) | 6.76025599 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 6.10780522 |
| 9 | long-chain fatty acid biosynthetic process (GO:0042759) | 6.10318527 |
| 10 | cellular potassium ion homeostasis (GO:0030007) | 5.86062051 |
| 11 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.73442929 |
| 12 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.69643903 |
| 13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.68534925 |
| 14 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.45809468 |
| 15 | oligodendrocyte differentiation (GO:0048709) | 5.34622839 |
| 16 | sodium ion export (GO:0071436) | 5.24363671 |
| 17 | amino acid import (GO:0043090) | 5.23711659 |
| 18 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.16939469 |
| 19 | myelin maintenance (GO:0043217) | 5.07095624 |
| 20 | virion attachment to host cell (GO:0019062) | 4.96731103 |
| 21 | adhesion of symbiont to host cell (GO:0044650) | 4.96731103 |
| 22 | regulation of synaptic vesicle transport (GO:1902803) | 4.95289429 |
| 23 | neurotransmitter secretion (GO:0007269) | 4.85240571 |
| 24 | glycerophospholipid catabolic process (GO:0046475) | 4.79959866 |
| 25 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.77605527 |
| 26 | creatine metabolic process (GO:0006600) | 4.75391223 |
| 27 | locomotory exploration behavior (GO:0035641) | 4.71900215 |
| 28 | cholesterol biosynthetic process (GO:0006695) | 4.66646828 |
| 29 | apical protein localization (GO:0045176) | 4.62771904 |
| 30 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.59221993 |
| 31 | asymmetric protein localization (GO:0008105) | 4.53892166 |
| 32 | negative regulation of neurotransmitter transport (GO:0051589) | 4.52754773 |
| 33 | astrocyte development (GO:0014002) | 4.50262955 |
| 34 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.45602219 |
| 35 | presynaptic membrane organization (GO:0097090) | 4.40582790 |
| 36 | potassium ion homeostasis (GO:0055075) | 4.37759469 |
| 37 | cerebellar granule cell differentiation (GO:0021707) | 4.27833470 |
| 38 | presynaptic membrane assembly (GO:0097105) | 4.27250261 |
| 39 | negative regulation of protein localization to cell surface (GO:2000009) | 4.25540197 |
| 40 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.23737671 |
| 41 | potassium ion import (GO:0010107) | 4.23439773 |
| 42 | establishment of mitochondrion localization (GO:0051654) | 4.23143027 |
| 43 | neuronal action potential propagation (GO:0019227) | 4.22972650 |
| 44 | photoreceptor cell differentiation (GO:0046530) | 4.21684917 |
| 45 | eye photoreceptor cell differentiation (GO:0001754) | 4.21684917 |
| 46 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.18378515 |
| 47 | substantia nigra development (GO:0021762) | 4.16552412 |
| 48 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.14847938 |
| 49 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.11860643 |
| 50 | regulation of collateral sprouting (GO:0048670) | 4.09855868 |
| 51 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 4.04755763 |
| 52 | sterol biosynthetic process (GO:0016126) | 4.04438077 |
| 53 | vocalization behavior (GO:0071625) | 4.03277490 |
| 54 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.03055860 |
| 55 | neurotransmitter transport (GO:0006836) | 4.02030384 |
| 56 | exploration behavior (GO:0035640) | 3.97150751 |
| 57 | positive regulation of synapse maturation (GO:0090129) | 3.96735079 |
| 58 | response to redox state (GO:0051775) | 3.93032944 |
| 59 | synaptic transmission, glutamatergic (GO:0035249) | 3.92005944 |
| 60 | positive regulation of action potential (GO:0045760) | 3.91202330 |
| 61 | neurotransmitter uptake (GO:0001504) | 3.85954042 |
| 62 | positive regulation of dendritic spine development (GO:0060999) | 3.81830646 |
| 63 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.81567688 |
| 64 | regulation of synaptic plasticity (GO:0048167) | 3.79753112 |
| 65 | postsynaptic membrane organization (GO:0001941) | 3.79518279 |
| 66 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.78896412 |
| 67 | adhesion of symbiont to host (GO:0044406) | 3.77378613 |
| 68 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.75925196 |
| 69 | acidic amino acid transport (GO:0015800) | 3.73442997 |
| 70 | negative regulation of JUN kinase activity (GO:0043508) | 3.71524889 |
| 71 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.70766066 |
| 72 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.70662867 |
| 73 | regulation of neurotransmitter levels (GO:0001505) | 3.67201478 |
| 74 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.65984711 |
| 75 | neuron-neuron synaptic transmission (GO:0007270) | 3.65934590 |
| 76 | regulation of ARF protein signal transduction (GO:0032012) | 3.62984948 |
| 77 | regulation of neurotransmitter secretion (GO:0046928) | 3.62977269 |
| 78 | myelination in peripheral nervous system (GO:0022011) | 3.61264746 |
| 79 | peripheral nervous system axon ensheathment (GO:0032292) | 3.61264746 |
| 80 | positive regulation of membrane potential (GO:0045838) | 3.60778508 |
| 81 | isoprenoid biosynthetic process (GO:0008299) | 3.60593370 |
| 82 | membrane tubulation (GO:0097320) | 3.59550296 |
| 83 | neuromuscular process controlling balance (GO:0050885) | 3.58804354 |
| 84 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.58587196 |
| 85 | glutamate receptor signaling pathway (GO:0007215) | 3.58521083 |
| 86 | import into cell (GO:0098657) | 3.58249848 |
| 87 | GPI anchor biosynthetic process (GO:0006506) | 3.57623130 |
| 88 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.56957626 |
| 89 | protein palmitoylation (GO:0018345) | 3.56247856 |
| 90 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.55685703 |
| 91 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.54508977 |
| 92 | protein localization to synapse (GO:0035418) | 3.47865973 |
| 93 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.46663582 |
| 94 | GPI anchor metabolic process (GO:0006505) | 3.46217682 |
| 95 | gamma-aminobutyric acid transport (GO:0015812) | 3.45750833 |
| 96 | phosphorelay signal transduction system (GO:0000160) | 3.45739142 |
| 97 | response to lipoprotein particle (GO:0055094) | 3.45129110 |
| 98 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.43773876 |
| 99 | positive regulation of Rap GTPase activity (GO:0032854) | 3.42969233 |
| 100 | amyloid precursor protein metabolic process (GO:0042982) | 3.42164697 |
| 101 | long-term synaptic potentiation (GO:0060291) | 3.42088915 |
| 102 | cell communication by electrical coupling (GO:0010644) | 3.41800104 |
| 103 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.39701466 |
| 104 | regulation of neurotransmitter transport (GO:0051588) | 3.38666984 |
| 105 | cellular sodium ion homeostasis (GO:0006883) | 3.38614394 |
| 106 | L-glutamate transport (GO:0015813) | 3.35059271 |
| 107 | negative regulation of inclusion body assembly (GO:0090084) | 3.31165685 |
| 108 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.30669177 |
| 109 | synaptic vesicle endocytosis (GO:0048488) | 3.30587251 |
| 110 | regulation of dendritic spine development (GO:0060998) | 3.29241728 |
| 111 | limb bud formation (GO:0060174) | 3.29072277 |
| 112 | L-amino acid import (GO:0043092) | 3.28811098 |
| 113 | negative regulation of axonogenesis (GO:0050771) | 3.25416874 |
| 114 | transmission of nerve impulse (GO:0019226) | 3.23665480 |
| 115 | regulation of postsynaptic membrane potential (GO:0060078) | 3.23025681 |
| 116 | regulation of Rap GTPase activity (GO:0032317) | 3.21203876 |
| 117 | glycosylceramide metabolic process (GO:0006677) | 3.21175105 |
| 118 | nucleotide transmembrane transport (GO:1901679) | 3.20961008 |
| 119 | long-term memory (GO:0007616) | 3.19797415 |
| 120 | cellular response to epinephrine stimulus (GO:0071872) | 3.19772991 |
| 121 | adult walking behavior (GO:0007628) | 3.18672242 |
| 122 | magnesium ion transport (GO:0015693) | 3.18048429 |
| 123 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.16672787 |
| 124 | regulation of synapse maturation (GO:0090128) | 3.16592392 |
| 125 | regulation of synapse structural plasticity (GO:0051823) | 3.16215293 |
| 126 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.15793798 |
| 127 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.14724355 |
| 128 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.14378397 |
| 129 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.13170188 |
| 130 | membrane depolarization during action potential (GO:0086010) | 3.11306003 |
| 131 | regulation of synaptic transmission (GO:0050804) | 3.11187629 |
| 132 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.10774161 |
| 133 | regulation of vesicle fusion (GO:0031338) | 3.09920305 |
| 134 | glial cell development (GO:0021782) | 3.08708085 |
| 135 | axon development (GO:0061564) | 3.07131121 |
| 136 | positive regulation of dendrite development (GO:1900006) | 3.04317271 |
| 137 | positive regulation of neurotransmitter transport (GO:0051590) | 3.02931617 |
| 138 | neuron cell-cell adhesion (GO:0007158) | 3.02449796 |
| 139 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.01839701 |
| 140 | ear development (GO:0043583) | 3.01821528 |
| 141 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.01259745 |
| 142 | peptidyl-cysteine modification (GO:0018198) | 2.99878456 |
| 143 | membrane depolarization (GO:0051899) | 2.97916726 |
| 144 | negative regulation of acute inflammatory response (GO:0002674) | 2.97753084 |
| 145 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.94684544 |
| 146 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.92236277 |
| 147 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.92065012 |
| 148 | synaptic transmission (GO:0007268) | 2.91221594 |
| 149 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.88922370 |
| 150 | cell differentiation in hindbrain (GO:0021533) | 2.88326272 |
| 151 | peripheral nervous system development (GO:0007422) | 2.86454599 |
| 152 | response to methylmercury (GO:0051597) | 2.85854412 |
| 153 | L-serine transport (GO:0015825) | 2.84673340 |
| 154 | positive regulation of glial cell differentiation (GO:0045687) | 2.84081255 |
| 155 | Leydig cell differentiation (GO:0033327) | 2.83436757 |
| 156 | very long-chain fatty acid metabolic process (GO:0000038) | 2.80208592 |
| 157 | membrane assembly (GO:0071709) | 2.79896084 |
| 158 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.79443014 |
| 159 | amyloid precursor protein catabolic process (GO:0042987) | 2.79138015 |
| 160 | response to epinephrine (GO:0071871) | 2.79116065 |
| 161 | neuron remodeling (GO:0016322) | 2.78300313 |
| 162 | neural nucleus development (GO:0048857) | 2.77511357 |
| 163 | neurotransmitter catabolic process (GO:0042135) | 2.74336863 |
| 164 | histone H2B ubiquitination (GO:0033523) | 2.70262192 |
| 165 | organ growth (GO:0035265) | 2.68875973 |
| 166 | microtubule polymerization or depolymerization (GO:0031109) | 2.67890345 |
| 167 | neuronal ion channel clustering (GO:0045161) | 2.67858434 |
| 168 | negative regulation of axon extension (GO:0030517) | 2.66235788 |
| 169 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.66130701 |
| 170 | glial cell differentiation (GO:0010001) | 2.64673725 |
| 171 | response to lead ion (GO:0010288) | 2.63259688 |
| 172 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.62499733 |
| 173 | L-phenylalanine catabolic process (GO:0006559) | 2.62499733 |
| 174 | positive regulation of interleukin-17 production (GO:0032740) | 2.61582254 |
| 175 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.61389335 |
| 176 | acyl-CoA biosynthetic process (GO:0071616) | 2.61057648 |
| 177 | thioester biosynthetic process (GO:0035384) | 2.61057648 |
| 178 | heme transport (GO:0015886) | 2.60851875 |
| 179 | positive regulation of gliogenesis (GO:0014015) | 2.60573543 |
| 180 | protein localization to endosome (GO:0036010) | 2.60397789 |
| 181 | iron coordination entity transport (GO:1901678) | 2.58510303 |
| 182 | central nervous system myelination (GO:0022010) | 11.9310603 |
| 183 | axon ensheathment in central nervous system (GO:0032291) | 11.9310603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.56253473 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.16438178 |
| 3 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.92699466 |
| 4 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.78115746 |
| 5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.62687165 |
| 6 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.56948472 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.56138416 |
| 8 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.36697784 |
| 9 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.27116970 |
| 10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.21952077 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.16068321 |
| 12 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.14723034 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.12158238 |
| 14 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.06161923 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.05651054 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.94223748 |
| 17 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.93248026 |
| 18 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.90993339 |
| 19 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.90993339 |
| 20 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.89990095 |
| 21 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.89724273 |
| 22 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.88641423 |
| 23 | VDR_22108803_ChIP-Seq_LS180_Human | 1.88107949 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.79163866 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.78318264 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.78282198 |
| 27 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.77808956 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.75332481 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.73289890 |
| 30 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.72697118 |
| 31 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.68758270 |
| 32 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.67085004 |
| 33 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.66062685 |
| 34 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.63522302 |
| 35 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.63024065 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.60026202 |
| 37 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.59626065 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56389933 |
| 39 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.55320304 |
| 40 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.54762349 |
| 41 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.54550644 |
| 42 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.52886882 |
| 43 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.52286295 |
| 44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.49934201 |
| 45 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.48442611 |
| 46 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.47742854 |
| 47 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.47164765 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.46780663 |
| 49 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.43709088 |
| 50 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.42571920 |
| 51 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.38504589 |
| 52 | FUS_26573619_Chip-Seq_HEK293_Human | 1.36246110 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.36013357 |
| 54 | KDM2B_26808549_Chip-Seq_K562_Human | 1.34469267 |
| 55 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.34106658 |
| 56 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32565947 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31863662 |
| 58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.30860146 |
| 59 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.29949528 |
| 60 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.29490541 |
| 61 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29488474 |
| 62 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28345661 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.27736581 |
| 64 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25061386 |
| 65 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.24889685 |
| 66 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.23280508 |
| 67 | AR_19668381_ChIP-Seq_PC3_Human | 1.23020318 |
| 68 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.22410731 |
| 69 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21565336 |
| 70 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.21183943 |
| 71 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.19485744 |
| 72 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.18848427 |
| 73 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17533383 |
| 74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.16371115 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.16371115 |
| 76 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.15888450 |
| 77 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.15640835 |
| 78 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.15388896 |
| 79 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15285965 |
| 80 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.14448803 |
| 81 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.13869527 |
| 82 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13768265 |
| 83 | P300_19829295_ChIP-Seq_ESCs_Human | 1.13591957 |
| 84 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.13552669 |
| 85 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.12056589 |
| 86 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.11939759 |
| 87 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.11281294 |
| 88 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.10894841 |
| 89 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.10612265 |
| 90 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.08897996 |
| 91 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08023068 |
| 92 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.07241956 |
| 93 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07125562 |
| 94 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.07079397 |
| 95 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.06726759 |
| 96 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.05968566 |
| 97 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.05820389 |
| 98 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04455755 |
| 99 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03894310 |
| 100 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.02340910 |
| 101 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.01582689 |
| 102 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.01509670 |
| 103 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.01336627 |
| 104 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.00182387 |
| 105 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.99763682 |
| 106 | STAT3_23295773_ChIP-Seq_U87_Human | 0.99702733 |
| 107 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.99575368 |
| 108 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.99539913 |
| 109 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98930172 |
| 110 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.98535791 |
| 111 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98139119 |
| 112 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.97914386 |
| 113 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.97805075 |
| 114 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97339897 |
| 115 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.96840178 |
| 116 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95574535 |
| 117 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95449224 |
| 118 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94123329 |
| 119 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94087435 |
| 120 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93841590 |
| 121 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.92922325 |
| 122 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92489870 |
| 123 | TCF4_23295773_ChIP-Seq_U87_Human | 0.92331474 |
| 124 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92018169 |
| 125 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91901197 |
| 126 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91688403 |
| 127 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.91211197 |
| 128 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91201926 |
| 129 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.90854955 |
| 130 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90392560 |
| 131 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89861736 |
| 132 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.89861736 |
| 133 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.89197056 |
| 134 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.88832565 |
| 135 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88767344 |
| 136 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.88284883 |
| 137 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88134987 |
| 138 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.87557603 |
| 139 | * TBL1_22424771_ChIP-Seq_293T_Human | 0.86736221 |
| 140 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.86408730 |
| 141 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.85495064 |
| 142 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85021414 |
| 143 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.84924129 |
| 144 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.84512365 |
| 145 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.84150618 |
| 146 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.81895734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.91405158 |
| 2 | MP0003950_abnormal_plasma_membrane | 3.95424838 |
| 3 | MP0003880_abnormal_central_pattern | 3.83760385 |
| 4 | MP0004270_analgesia | 3.53222811 |
| 5 | MP0003690_abnormal_glial_cell | 3.17324753 |
| 6 | MP0004885_abnormal_endolymph | 2.77013551 |
| 7 | MP0003136_yellow_coat_color | 2.74484835 |
| 8 | MP0001529_abnormal_vocalization | 2.71826699 |
| 9 | MP0001905_abnormal_dopamine_level | 2.61593381 |
| 10 | MP0003329_amyloid_beta_deposits | 2.59241418 |
| 11 | MP0005171_absent_coat_pigmentation | 2.51215556 |
| 12 | MP0003634_abnormal_glial_cell | 2.49213099 |
| 13 | MP0004742_abnormal_vestibular_system | 2.45566665 |
| 14 | MP0005451_abnormal_body_composition | 2.41331902 |
| 15 | MP0002272_abnormal_nervous_system | 2.37717480 |
| 16 | MP0004142_abnormal_muscle_tone | 2.31346873 |
| 17 | MP0001486_abnormal_startle_reflex | 2.27817716 |
| 18 | MP0001485_abnormal_pinna_reflex | 2.26545377 |
| 19 | MP0005409_darkened_coat_color | 2.13427974 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.12965885 |
| 21 | MP0000778_abnormal_nervous_system | 2.09430391 |
| 22 | MP0003879_abnormal_hair_cell | 2.07122265 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 2.05916435 |
| 24 | MP0002064_seizures | 2.02928647 |
| 25 | MP0002229_neurodegeneration | 1.95951621 |
| 26 | MP0005410_abnormal_fertilization | 1.93134210 |
| 27 | MP0003632_abnormal_nervous_system | 1.90275228 |
| 28 | MP0009780_abnormal_chondrocyte_physiolo | 1.90251434 |
| 29 | MP0004147_increased_porphyrin_level | 1.90163239 |
| 30 | MP0004859_abnormal_synaptic_plasticity | 1.88388411 |
| 31 | MP0000383_abnormal_hair_follicle | 1.88015881 |
| 32 | MP0010678_abnormal_skin_adnexa | 1.79820095 |
| 33 | MP0004381_abnormal_hair_follicle | 1.79173581 |
| 34 | MP0001984_abnormal_olfaction | 1.77519080 |
| 35 | MP0000462_abnormal_digestive_system | 1.77176218 |
| 36 | MP0009046_muscle_twitch | 1.75209718 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.74612505 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.69674539 |
| 39 | MP0002736_abnormal_nociception_after | 1.63931909 |
| 40 | MP0002734_abnormal_mechanical_nocicepti | 1.63716669 |
| 41 | MP0004043_abnormal_pH_regulation | 1.59196171 |
| 42 | MP0001661_extended_life_span | 1.53053566 |
| 43 | MP0009745_abnormal_behavioral_response | 1.51830836 |
| 44 | MP0001346_abnormal_lacrimal_gland | 1.50110278 |
| 45 | MP0003787_abnormal_imprinting | 1.49090863 |
| 46 | MP0000955_abnormal_spinal_cord | 1.46225176 |
| 47 | MP0000566_synostosis | 1.46202980 |
| 48 | MP0003635_abnormal_synaptic_transmissio | 1.41509658 |
| 49 | MP0001502_abnormal_circadian_rhythm | 1.38841752 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.36323280 |
| 51 | MP0005423_abnormal_somatic_nervous | 1.34622171 |
| 52 | MP0000604_amyloidosis | 1.34006221 |
| 53 | MP0005551_abnormal_eye_electrophysiolog | 1.33756626 |
| 54 | MP0002882_abnormal_neuron_morphology | 1.32004390 |
| 55 | MP0004134_abnormal_chest_morphology | 1.25654288 |
| 56 | MP0001440_abnormal_grooming_behavior | 1.24744792 |
| 57 | MP0001299_abnormal_eye_distance/ | 1.22263087 |
| 58 | MP0008260_abnormal_autophagy | 1.21331633 |
| 59 | MP0001963_abnormal_hearing_physiology | 1.20134757 |
| 60 | MP0002066_abnormal_motor_capabilities/c | 1.18019794 |
| 61 | MP0002752_abnormal_somatic_nervous | 1.17326510 |
| 62 | MP0003631_nervous_system_phenotype | 1.17051864 |
| 63 | MP0000747_muscle_weakness | 1.15859851 |
| 64 | MP0004924_abnormal_behavior | 1.12676507 |
| 65 | MP0005386_behavior/neurological_phenoty | 1.12676507 |
| 66 | MP0005408_hypopigmentation | 1.12645615 |
| 67 | MP0001851_eye_inflammation | 1.09389066 |
| 68 | MP0002572_abnormal_emotion/affect_behav | 1.06980966 |
| 69 | MP0005167_abnormal_blood-brain_barrier | 1.05446310 |
| 70 | MP0008438_abnormal_cutaneous_collagen | 1.04735467 |
| 71 | MP0003938_abnormal_ear_development | 1.04325639 |
| 72 | MP0006082_CNS_inflammation | 1.02386928 |
| 73 | MP0001348_abnormal_lacrimal_gland | 1.01879161 |
| 74 | MP0008874_decreased_physiological_sensi | 1.01642328 |
| 75 | MP0003123_paternal_imprinting | 1.01249287 |
| 76 | MP0006276_abnormal_autonomic_nervous | 1.00739184 |
| 77 | MP0001970_abnormal_pain_threshold | 1.00390154 |
| 78 | MP0005058_abnormal_lysosome_morphology | 1.00251747 |
| 79 | MP0003075_altered_response_to | 0.99741606 |
| 80 | MP0002067_abnormal_sensory_capabilities | 0.99674774 |
| 81 | MP0005195_abnormal_posterior_eye | 0.99361457 |
| 82 | MP0002822_catalepsy | 0.98899913 |
| 83 | MP0005623_abnormal_meninges_morphology | 0.97046449 |
| 84 | MP0003195_calcinosis | 0.96694489 |
| 85 | MP0008569_lethality_at_weaning | 0.96034781 |
| 86 | MP0003937_abnormal_limbs/digits/tail_de | 0.94777995 |
| 87 | MP0004185_abnormal_adipocyte_glucose | 0.94072765 |
| 88 | MP0000762_abnormal_tongue_morphology | 0.93064005 |
| 89 | MP0000647_abnormal_sebaceous_gland | 0.92074673 |
| 90 | MP0001727_abnormal_embryo_implantation | 0.91983961 |
| 91 | MP0002295_abnormal_pulmonary_circulatio | 0.91373147 |
| 92 | MP0002063_abnormal_learning/memory/cond | 0.87384559 |
| 93 | MP0000569_abnormal_digit_pigmentation | 0.85985853 |
| 94 | MP0003122_maternal_imprinting | 0.83757322 |
| 95 | MP0000026_abnormal_inner_ear | 0.83425899 |
| 96 | MP0004145_abnormal_muscle_electrophysio | 0.80997444 |
| 97 | MP0002733_abnormal_thermal_nociception | 0.80894286 |
| 98 | MP0006072_abnormal_retinal_apoptosis | 0.80548775 |
| 99 | MP0000579_abnormal_nail_morphology | 0.79059732 |
| 100 | MP0003633_abnormal_nervous_system | 0.78096220 |
| 101 | MP0000467_abnormal_esophagus_morphology | 0.77564065 |
| 102 | MP0002152_abnormal_brain_morphology | 0.75961336 |
| 103 | MP0001986_abnormal_taste_sensitivity | 0.75190953 |
| 104 | MP0003045_fibrosis | 0.73921760 |
| 105 | MP0002638_abnormal_pupillary_reflex | 0.71216306 |
| 106 | MP0004133_heterotaxia | 0.70065831 |
| 107 | MP0005253_abnormal_eye_physiology | 0.67450883 |
| 108 | MP0002069_abnormal_eating/drinking_beha | 0.64934320 |
| 109 | MP0001177_atelectasis | 0.63407180 |
| 110 | MP0002938_white_spotting | 0.62314409 |
| 111 | MP0004036_abnormal_muscle_relaxation | 0.61224322 |
| 112 | MP0001340_abnormal_eyelid_morphology | 0.60857016 |
| 113 | MP0005535_abnormal_body_temperature | 0.59633283 |
| 114 | MP0002735_abnormal_chemical_nociception | 0.58776178 |
| 115 | MP0003137_abnormal_impulse_conducting | 0.58398751 |
| 116 | MP0008872_abnormal_physiological_respon | 0.57529479 |
| 117 | MP0010386_abnormal_urinary_bladder | 0.57008475 |
| 118 | MP0008877_abnormal_DNA_methylation | 0.56644265 |
| 119 | MP0010769_abnormal_survival | 0.56130497 |
| 120 | MP0004130_abnormal_muscle_cell | 0.55616493 |
| 121 | MP0002184_abnormal_innervation | 0.54225451 |
| 122 | MP0002909_abnormal_adrenal_gland | 0.53240119 |
| 123 | MP0000372_irregular_coat_pigmentation | 0.53208711 |
| 124 | MP0010768_mortality/aging | 0.52285776 |
| 125 | MP0010770_preweaning_lethality | 0.51808207 |
| 126 | MP0002082_postnatal_lethality | 0.51808207 |
| 127 | MP0002933_joint_inflammation | 0.50860204 |
| 128 | MP0005388_respiratory_system_phenotype | 0.50604566 |
| 129 | MP0002133_abnormal_respiratory_system | 0.50604566 |
| 130 | MP0002090_abnormal_vision | 0.49807681 |
| 131 | MP0001968_abnormal_touch/_nociception | 0.49805634 |
| 132 | MP0000631_abnormal_neuroendocrine_gland | 0.49793852 |
| 133 | MP0001943_abnormal_respiration | 0.47247317 |
| 134 | MP0003183_abnormal_peptide_metabolism | 0.46616499 |
| 135 | MP0005645_abnormal_hypothalamus_physiol | 0.45705710 |
| 136 | MP0005166_decreased_susceptibility_to | 0.45302244 |
| 137 | MP0003956_abnormal_body_size | 0.45295934 |
| 138 | MP0003172_abnormal_lysosome_physiology | 0.44846814 |
| 139 | MP0002089_abnormal_postnatal_growth/wei | 0.42288152 |
| 140 | MP0003861_abnormal_nervous_system | 0.41817319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.69741774 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.69741774 |
| 3 | Focal motor seizures (HP:0011153) | 6.63249204 |
| 4 | Neurofibrillary tangles (HP:0002185) | 6.15521277 |
| 5 | Sensory axonal neuropathy (HP:0003390) | 5.71634162 |
| 6 | Action tremor (HP:0002345) | 5.53627901 |
| 7 | Parakeratosis (HP:0001036) | 5.52041382 |
| 8 | Focal seizures (HP:0007359) | 5.43693586 |
| 9 | Abnormality of the corticospinal tract (HP:0002492) | 4.91049547 |
| 10 | Febrile seizures (HP:0002373) | 4.78014934 |
| 11 | Epileptic encephalopathy (HP:0200134) | 4.72347684 |
| 12 | Diplopia (HP:0000651) | 4.58109878 |
| 13 | Abnormality of binocular vision (HP:0011514) | 4.58109878 |
| 14 | Cerebral inclusion bodies (HP:0100314) | 4.33327797 |
| 15 | Peripheral hypomyelination (HP:0007182) | 4.30464056 |
| 16 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.28293107 |
| 17 | Cerebral hypomyelination (HP:0006808) | 3.95931700 |
| 18 | Spastic gait (HP:0002064) | 3.57757484 |
| 19 | Postural instability (HP:0002172) | 3.55743210 |
| 20 | Generalized tonic-clonic seizures (HP:0002069) | 3.55635354 |
| 21 | Alacrima (HP:0000522) | 3.48146067 |
| 22 | Supranuclear gaze palsy (HP:0000605) | 3.47531742 |
| 23 | Onion bulb formation (HP:0003383) | 3.45061870 |
| 24 | Abnormal eating behavior (HP:0100738) | 3.42768418 |
| 25 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.42358851 |
| 26 | Papilledema (HP:0001085) | 3.36331205 |
| 27 | Akinesia (HP:0002304) | 3.35761109 |
| 28 | Progressive cerebellar ataxia (HP:0002073) | 3.34291192 |
| 29 | Increased serum pyruvate (HP:0003542) | 3.31857772 |
| 30 | Abnormality of glycolysis (HP:0004366) | 3.31857772 |
| 31 | Visual hallucinations (HP:0002367) | 3.28159488 |
| 32 | Urinary urgency (HP:0000012) | 3.21115534 |
| 33 | Absence seizures (HP:0002121) | 3.18340782 |
| 34 | Intention tremor (HP:0002080) | 3.16852092 |
| 35 | Abnormal auditory evoked potentials (HP:0006958) | 3.16096289 |
| 36 | Dialeptic seizures (HP:0011146) | 3.10971834 |
| 37 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.08063497 |
| 38 | Obstructive sleep apnea (HP:0002870) | 3.07264054 |
| 39 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.07247811 |
| 40 | Spastic paraparesis (HP:0002313) | 3.03169206 |
| 41 | Truncal ataxia (HP:0002078) | 2.98540599 |
| 42 | Hemiplegia (HP:0002301) | 2.98354199 |
| 43 | Dysmetria (HP:0001310) | 2.97494260 |
| 44 | Thickened helices (HP:0000391) | 2.95113482 |
| 45 | Leukodystrophy (HP:0002415) | 2.92532766 |
| 46 | Anteriorly placed anus (HP:0001545) | 2.84944195 |
| 47 | Torticollis (HP:0000473) | 2.84236402 |
| 48 | Neuronal loss in central nervous system (HP:0002529) | 2.83041829 |
| 49 | Mutism (HP:0002300) | 2.77317903 |
| 50 | Autoamputation (HP:0001218) | 2.74468077 |
| 51 | Clonus (HP:0002169) | 2.73337183 |
| 52 | Dysdiadochokinesis (HP:0002075) | 2.73234265 |
| 53 | Tetraplegia (HP:0002445) | 2.73018541 |
| 54 | Limb dystonia (HP:0002451) | 2.71717427 |
| 55 | Premature skin wrinkling (HP:0100678) | 2.71666695 |
| 56 | Decreased lacrimation (HP:0000633) | 2.71170456 |
| 57 | Slow saccadic eye movements (HP:0000514) | 2.71092596 |
| 58 | Hypoplastic pelvis (HP:0008839) | 2.69538742 |
| 59 | Choreoathetosis (HP:0001266) | 2.68418299 |
| 60 | Bundle branch block (HP:0011710) | 2.65888823 |
| 61 | Absent septum pellucidum (HP:0001331) | 2.64327305 |
| 62 | Stridor (HP:0010307) | 2.63588457 |
| 63 | Insidious onset (HP:0003587) | 2.60978272 |
| 64 | Termporal pattern (HP:0011008) | 2.60978272 |
| 65 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.59821111 |
| 66 | Depression (HP:0000716) | 2.58469807 |
| 67 | Bradykinesia (HP:0002067) | 2.56577576 |
| 68 | Renal Fanconi syndrome (HP:0001994) | 2.55819811 |
| 69 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.55156805 |
| 70 | Status epilepticus (HP:0002133) | 2.55128922 |
| 71 | Delusions (HP:0000746) | 2.54761973 |
| 72 | Apathy (HP:0000741) | 2.51426654 |
| 73 | Myokymia (HP:0002411) | 2.50946222 |
| 74 | Epileptiform EEG discharges (HP:0011182) | 2.50184302 |
| 75 | Annular pancreas (HP:0001734) | 2.48559445 |
| 76 | Poor eye contact (HP:0000817) | 2.47480300 |
| 77 | Cerebral hemorrhage (HP:0001342) | 2.47345024 |
| 78 | Scanning speech (HP:0002168) | 2.46165030 |
| 79 | Infantile muscular hypotonia (HP:0008947) | 2.44508255 |
| 80 | Split foot (HP:0001839) | 2.43417721 |
| 81 | Hemiparesis (HP:0001269) | 2.41919265 |
| 82 | Rigidity (HP:0002063) | 2.39381085 |
| 83 | Sleep apnea (HP:0010535) | 2.39270905 |
| 84 | Hepatosplenomegaly (HP:0001433) | 2.37699284 |
| 85 | Retinal dysplasia (HP:0007973) | 2.36942252 |
| 86 | CNS hypomyelination (HP:0003429) | 2.35899799 |
| 87 | Anxiety (HP:0000739) | 2.33678463 |
| 88 | Focal dystonia (HP:0004373) | 2.31777673 |
| 89 | Rapidly progressive (HP:0003678) | 2.29222829 |
| 90 | Insomnia (HP:0100785) | 2.29153690 |
| 91 | Partial agenesis of the corpus callosum (HP:0001338) | 2.28832257 |
| 92 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.26919392 |
| 93 | Abnormality of the septum pellucidum (HP:0007375) | 2.26630876 |
| 94 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.26180784 |
| 95 | Clumsiness (HP:0002312) | 2.26082405 |
| 96 | Coronal craniosynostosis (HP:0004440) | 2.25889164 |
| 97 | Diminished motivation (HP:0000745) | 2.22528356 |
| 98 | Impaired vibratory sensation (HP:0002495) | 2.21017863 |
| 99 | Muscle fiber splitting (HP:0003555) | 2.20403709 |
| 100 | Humeroradial synostosis (HP:0003041) | 2.15776470 |
| 101 | Synostosis involving the elbow (HP:0003938) | 2.15776470 |
| 102 | Increased circulating renin level (HP:0000848) | 2.14603922 |
| 103 | Craniofacial dystonia (HP:0012179) | 2.14584050 |
| 104 | Spastic paraplegia (HP:0001258) | 2.14462714 |
| 105 | EEG with generalized epileptiform discharges (HP:0011198) | 2.13648951 |
| 106 | Erythroderma (HP:0001019) | 2.13614070 |
| 107 | Cupped ear (HP:0000378) | 2.12635556 |
| 108 | Impaired smooth pursuit (HP:0007772) | 2.12231814 |
| 109 | White forelock (HP:0002211) | 2.10089449 |
| 110 | Broad-based gait (HP:0002136) | 2.09980557 |
| 111 | Morphological abnormality of the inner ear (HP:0011390) | 2.09907053 |
| 112 | Partial duplication of thumb phalanx (HP:0009944) | 2.09384359 |
| 113 | Hypomagnesemia (HP:0002917) | 2.07682838 |
| 114 | Paraplegia (HP:0010550) | 2.07433336 |
| 115 | Patchy hypopigmentation of hair (HP:0011365) | 2.06448951 |
| 116 | Impaired social interactions (HP:0000735) | 2.06082213 |
| 117 | Abnormal social behavior (HP:0012433) | 2.06082213 |
| 118 | Abnormality of the periventricular white matter (HP:0002518) | 2.04823472 |
| 119 | Adrenal hypoplasia (HP:0000835) | 2.04089764 |
| 120 | Megalencephaly (HP:0001355) | 2.04049901 |
| 121 | Ankle clonus (HP:0011448) | 2.03596056 |
| 122 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.99633574 |
| 123 | Aplasia of the phalanges of the hand (HP:0009802) | 1.99633574 |
| 124 | Aplasia involving bones of the extremities (HP:0009825) | 1.99633574 |
| 125 | 3-Methylglutaconic aciduria (HP:0003535) | 1.99024638 |
| 126 | Gaze-evoked nystagmus (HP:0000640) | 1.98063330 |
| 127 | Abnormality of the lower motor neuron (HP:0002366) | 1.95945747 |
| 128 | Metabolic alkalosis (HP:0200114) | 1.95708915 |
| 129 | Methylmalonic acidemia (HP:0002912) | 1.95682907 |
| 130 | Paraparesis (HP:0002385) | 1.95427384 |
| 131 | Hypsarrhythmia (HP:0002521) | 1.94897249 |
| 132 | Abnormality of saccadic eye movements (HP:0000570) | 1.94609710 |
| 133 | Bronchomalacia (HP:0002780) | 1.94347082 |
| 134 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.93767758 |
| 135 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.93438027 |
| 136 | Memory impairment (HP:0002354) | 1.92267091 |
| 137 | Hypoplasia of the iris (HP:0007676) | 1.90859480 |
| 138 | Lower limb muscle weakness (HP:0007340) | 1.90642938 |
| 139 | Barrel-shaped chest (HP:0001552) | 1.90252159 |
| 140 | Hyporeflexia of lower limbs (HP:0002600) | 1.90098136 |
| 141 | Foot dorsiflexor weakness (HP:0009027) | 1.89804219 |
| 142 | Pheochromocytoma (HP:0002666) | 1.89107876 |
| 143 | Spastic tetraparesis (HP:0001285) | 1.87218480 |
| 144 | Stenosis of the external auditory canal (HP:0000402) | 1.87216296 |
| 145 | Bowel incontinence (HP:0002607) | 1.84898117 |
| 146 | Poor speech (HP:0002465) | 1.83917740 |
| 147 | Diminished movement (HP:0002374) | 1.82241128 |
| 148 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.81271286 |
| 149 | Hypokalemic alkalosis (HP:0001949) | 1.80985970 |
| 150 | Atonic seizures (HP:0010819) | 1.79255047 |
| 151 | Partial duplication of the phalanx of hand (HP:0009999) | 1.77672040 |
| 152 | Increased hepatocellular lipid droplets (HP:0006565) | 1.77169000 |
| 153 | Urinary incontinence (HP:0000020) | 1.76629733 |
| 154 | Generalized myoclonic seizures (HP:0002123) | 1.76408220 |
| 155 | Esophageal atresia (HP:0002032) | 1.76125456 |
| 156 | Abolished electroretinogram (ERG) (HP:0000550) | 1.76106102 |
| 157 | Prolonged neonatal jaundice (HP:0006579) | 1.75350506 |
| 158 | Decreased motor nerve conduction velocity (HP:0003431) | 1.74547418 |
| 159 | Vaginal atresia (HP:0000148) | 1.73731505 |
| 160 | Septo-optic dysplasia (HP:0100842) | 1.71868674 |
| 161 | Abnormal large intestine physiology (HP:0012700) | 1.71603411 |
| 162 | Myelomeningocele (HP:0002475) | 1.70860948 |
| 163 | Abnormality of the foot musculature (HP:0001436) | 1.68871203 |
| 164 | Neuroendocrine neoplasm (HP:0100634) | 1.67964419 |
| 165 | Gowers sign (HP:0003391) | 1.67122372 |
| 166 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.66585329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.46570927 |
| 2 | OXSR1 | 4.92794693 |
| 3 | NTRK3 | 4.26813603 |
| 4 | DAPK2 | 3.22269585 |
| 5 | CDK19 | 3.18107228 |
| 6 | BCR | 3.17662484 |
| 7 | EPHB1 | 2.76843659 |
| 8 | MET | 2.62660504 |
| 9 | WNK4 | 2.58274249 |
| 10 | PBK | 2.55516057 |
| 11 | MINK1 | 2.51050172 |
| 12 | PKN1 | 2.46955945 |
| 13 | PRPF4B | 2.29267194 |
| 14 | TNIK | 2.26847013 |
| 15 | LIMK1 | 2.26313364 |
| 16 | MAP3K9 | 2.22197181 |
| 17 | FGFR2 | 2.22085242 |
| 18 | PRKD3 | 2.21187317 |
| 19 | CAMKK1 | 2.16721034 |
| 20 | CSNK1G3 | 2.15223796 |
| 21 | CSNK1A1L | 2.08420424 |
| 22 | WNK1 | 2.05106820 |
| 23 | ICK | 2.03259599 |
| 24 | NEK6 | 2.02471127 |
| 25 | RIPK4 | 1.91911987 |
| 26 | CSNK1G1 | 1.70369784 |
| 27 | TESK2 | 1.63910948 |
| 28 | CSNK1G2 | 1.58924702 |
| 29 | UHMK1 | 1.56829587 |
| 30 | PNCK | 1.55057985 |
| 31 | PLK2 | 1.54332601 |
| 32 | CAMK2B | 1.53738152 |
| 33 | MST4 | 1.51399376 |
| 34 | ROCK2 | 1.49023309 |
| 35 | FGR | 1.44865616 |
| 36 | CAMK1 | 1.36412366 |
| 37 | PAK6 | 1.35781981 |
| 38 | NTRK1 | 1.35301148 |
| 39 | CAMK2D | 1.32029980 |
| 40 | MAPKAPK5 | 1.31221653 |
| 41 | PINK1 | 1.30493039 |
| 42 | GRK5 | 1.28417718 |
| 43 | LATS2 | 1.27903478 |
| 44 | CLK1 | 1.25412459 |
| 45 | EPHA4 | 1.20075745 |
| 46 | DAPK1 | 1.18402497 |
| 47 | MAPK13 | 1.17663540 |
| 48 | ALK | 1.14454088 |
| 49 | RIPK1 | 1.13399401 |
| 50 | SGK2 | 1.12366573 |
| 51 | BMPR2 | 1.08843668 |
| 52 | PRKCG | 1.07566715 |
| 53 | ARAF | 1.03415415 |
| 54 | CASK | 1.02765546 |
| 55 | CAMK2G | 1.00056785 |
| 56 | SGK1 | 0.98615708 |
| 57 | SGK3 | 0.98265599 |
| 58 | TRPM7 | 0.95586935 |
| 59 | CDK14 | 0.93606923 |
| 60 | ERBB4 | 0.93096249 |
| 61 | CAMKK2 | 0.89111058 |
| 62 | PRKCQ | 0.85802320 |
| 63 | MAPK15 | 0.84104479 |
| 64 | MAPK12 | 0.83657908 |
| 65 | BMPR1B | 0.83379398 |
| 66 | DYRK2 | 0.83134198 |
| 67 | STK38 | 0.82434912 |
| 68 | CDK15 | 0.81277440 |
| 69 | MARK1 | 0.80261729 |
| 70 | SIK2 | 0.80212261 |
| 71 | CDK5 | 0.78446793 |
| 72 | CDK18 | 0.75779129 |
| 73 | PAK3 | 0.75364569 |
| 74 | MAP3K13 | 0.75270485 |
| 75 | CAMK2A | 0.73986698 |
| 76 | CDK11A | 0.73766403 |
| 77 | SGK494 | 0.73630138 |
| 78 | SGK223 | 0.73630138 |
| 79 | MARK2 | 0.73329233 |
| 80 | TYRO3 | 0.70541234 |
| 81 | RPS6KA3 | 0.69780653 |
| 82 | CAMK4 | 0.63180890 |
| 83 | MAP3K4 | 0.62992668 |
| 84 | PDPK1 | 0.62381597 |
| 85 | BRSK1 | 0.58721225 |
| 86 | FYN | 0.58676369 |
| 87 | MAP3K11 | 0.58588595 |
| 88 | PHKG1 | 0.55724283 |
| 89 | PHKG2 | 0.55724283 |
| 90 | PRKD1 | 0.55258876 |
| 91 | MUSK | 0.54742563 |
| 92 | KSR1 | 0.52351576 |
| 93 | CSNK1D | 0.52131703 |
| 94 | PRKCE | 0.51474990 |
| 95 | IRAK2 | 0.51467131 |
| 96 | MAP3K2 | 0.51402284 |
| 97 | TNK2 | 0.51268165 |
| 98 | ITK | 0.50934431 |
| 99 | MAP2K4 | 0.50924585 |
| 100 | RET | 0.49326224 |
| 101 | PRKCH | 0.49315512 |
| 102 | RPS6KA5 | 0.48933220 |
| 103 | PRKCZ | 0.47732030 |
| 104 | BRAF | 0.46572978 |
| 105 | FES | 0.45995197 |
| 106 | DAPK3 | 0.45939618 |
| 107 | PRKG1 | 0.45838192 |
| 108 | MAP3K1 | 0.42685932 |
| 109 | STK11 | 0.41917436 |
| 110 | RAF1 | 0.41216150 |
| 111 | PAK1 | 0.40408350 |
| 112 | CSNK1A1 | 0.39503588 |
| 113 | ROCK1 | 0.36345012 |
| 114 | PRKACB | 0.36145577 |
| 115 | PRKCA | 0.35122855 |
| 116 | PRKCB | 0.34003447 |
| 117 | JAK2 | 0.33277075 |
| 118 | STK16 | 0.33135371 |
| 119 | MAPK7 | 0.32972916 |
| 120 | PIK3CA | 0.32170623 |
| 121 | ADRBK2 | 0.31592917 |
| 122 | KSR2 | 0.31322614 |
| 123 | MAP3K12 | 0.30882722 |
| 124 | GSK3B | 0.30843573 |
| 125 | LMTK2 | 0.30712926 |
| 126 | OBSCN | 0.30482815 |
| 127 | BMX | 0.30276923 |
| 128 | GSK3A | 0.29204716 |
| 129 | MOS | 0.28969573 |
| 130 | PTK2B | 0.28594863 |
| 131 | GRK7 | 0.28418547 |
| 132 | PDGFRB | 0.28137009 |
| 133 | MAP2K2 | 0.26735351 |
| 134 | INSR | 0.26152546 |
| 135 | PDK1 | 0.25577233 |
| 136 | NME1 | 0.23635562 |
| 137 | DMPK | 0.23510477 |
| 138 | CSK | 0.22609102 |
| 139 | NUAK1 | 0.22367010 |
| 140 | CAMK1G | 0.21928253 |
| 141 | PRKACA | 0.21380599 |
| 142 | CSNK1E | 0.20919045 |
| 143 | DYRK1A | 0.20580981 |
| 144 | ABL1 | 0.19885277 |
| 145 | NTRK2 | 0.19668615 |
| 146 | LCK | 0.19619938 |
| 147 | MAPK10 | 0.18726721 |
| 148 | DDR2 | 0.18552100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.10989343 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.63240849 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.44375778 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.47503057 |
| 5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.41165053 |
| 6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.03878233 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.96804894 |
| 8 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.65135914 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.58543516 |
| 10 | Protein export_Homo sapiens_hsa03060 | 2.54565671 |
| 11 | Insulin secretion_Homo sapiens_hsa04911 | 2.46655939 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.43918508 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.33236416 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.21196446 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.16917031 |
| 16 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.97434178 |
| 17 | Axon guidance_Homo sapiens_hsa04360 | 1.97348736 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.87805696 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.79211788 |
| 20 | Parkinsons disease_Homo sapiens_hsa05012 | 1.75921364 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.72346164 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.72121748 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.70185588 |
| 24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.66032491 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.65340819 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.60847915 |
| 27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.55757946 |
| 28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.54937960 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.49379396 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.48598334 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.48034757 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.47524347 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.46907461 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.46467273 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 1.42874667 |
| 36 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.42601249 |
| 37 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.33343400 |
| 38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.26094386 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.24827415 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24387327 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.22475910 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.20364088 |
| 43 | Gap junction_Homo sapiens_hsa04540 | 1.18089701 |
| 44 | Olfactory transduction_Homo sapiens_hsa04740 | 1.13203864 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.09895023 |
| 46 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.09375200 |
| 47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.09069794 |
| 48 | Glioma_Homo sapiens_hsa05214 | 1.08982335 |
| 49 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.07142394 |
| 50 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.06095282 |
| 51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.05996237 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.05351830 |
| 53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04476612 |
| 54 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02835210 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.02732838 |
| 56 | GABAergic synapse_Homo sapiens_hsa04727 | 1.01635842 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98282759 |
| 58 | Tight junction_Homo sapiens_hsa04530 | 0.97240222 |
| 59 | Huntingtons disease_Homo sapiens_hsa05016 | 0.96592487 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.96351670 |
| 61 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.94864348 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.94745443 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94522363 |
| 64 | Melanogenesis_Homo sapiens_hsa04916 | 0.91458621 |
| 65 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.90802219 |
| 66 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.89913152 |
| 67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.89037108 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.86520421 |
| 69 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86384818 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85813770 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.84131206 |
| 72 | Morphine addiction_Homo sapiens_hsa05032 | 0.80582561 |
| 73 | Long-term depression_Homo sapiens_hsa04730 | 0.78265194 |
| 74 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.78008438 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77964108 |
| 76 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.77000162 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76205090 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.75374868 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75193439 |
| 80 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.73998290 |
| 81 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73919825 |
| 82 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72696331 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72172473 |
| 84 | Phototransduction_Homo sapiens_hsa04744 | 0.71615646 |
| 85 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.70151448 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68754255 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.68435508 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65735765 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.64362608 |
| 90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62401128 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62334570 |
| 92 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.61810760 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61503497 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61397563 |
| 95 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59890084 |
| 96 | Peroxisome_Homo sapiens_hsa04146 | 0.59594357 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58563138 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58409952 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55954769 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55424085 |
| 101 | Phagosome_Homo sapiens_hsa04145 | 0.54947319 |
| 102 | Cocaine addiction_Homo sapiens_hsa05030 | 0.54516313 |
| 103 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54382921 |
| 104 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.52475148 |
| 105 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52087530 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51880406 |
| 107 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50484123 |
| 108 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50007157 |
| 109 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48246231 |
| 110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47402691 |
| 111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46272123 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45494635 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.44527179 |
| 114 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.44279325 |
| 115 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.43456647 |
| 116 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.43113084 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42145380 |
| 118 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.41362617 |
| 119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40926257 |
| 120 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.40254875 |
| 121 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.40176270 |
| 122 | Nicotine addiction_Homo sapiens_hsa05033 | 0.38129036 |
| 123 | Circadian entrainment_Homo sapiens_hsa04713 | 0.38085735 |
| 124 | Salivary secretion_Homo sapiens_hsa04970 | 0.37927345 |
| 125 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37426654 |
| 126 | ABC transporters_Homo sapiens_hsa02010 | 0.36522661 |
| 127 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.35116334 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34742157 |
| 129 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34123138 |
| 130 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33576264 |
| 131 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33516204 |
| 132 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32091261 |
| 133 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31078050 |
| 134 | Basal transcription factors_Homo sapiens_hsa03022 | 0.30292216 |
| 135 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.27586204 |
| 136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27304047 |
| 137 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.26856538 |
| 138 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.26630899 |
| 139 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.26540203 |
| 140 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.25331456 |
| 141 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.25067835 |
| 142 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.24641190 |
| 143 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.24381319 |
| 144 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.24166257 |
| 145 | Asthma_Homo sapiens_hsa05310 | 0.23147102 |
| 146 | Alcoholism_Homo sapiens_hsa05034 | 0.21425306 |
| 147 | Salmonella infection_Homo sapiens_hsa05132 | 0.21040352 |
| 148 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.20178471 |
| 149 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.20087458 |
| 150 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.20031782 |
| 151 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.17946665 |

